NYSE:CRMD

Cormedix Stock News

Healthcare > Biotechnology

Buy CRMD

*Your capital is at risk

$8.23

+0.0600 (+0.734%)

At Close: Jun 03, 2026

CorMedix up 16% premarket on positive Neutrolin data

12:00am, Thursday, 17'th Jan 2019

Mid-Day Market Update: Crude Oil Up 3%; Bio-Path Holdings Shares Plummet

12:00am, Tuesday, 15'th Jan 2019

Cormedix closes $7.5M senior secured convertible debt financing

12:00am, Friday, 04'th Jan 2019

Implied Volatility Surging for CorMedix (CRMD) Stock Options

12:00am, Friday, 21'st Dec 2018

Cormedix Receives Approval To Sell $5.4M Of NOL Tax Benefits Through The New Jersey Economic Development Authority Program

12:00am, Monday, 10'th Dec 2018

CorMedix up 7%

12:00am, Friday, 07'th Dec 2018

CorMedix Exec VP of Tech Operations Armstrong Buys 250,000 @ Avg Price: $1.45

12:00am, Friday, 30'th Nov 2018

CorMedix rebounds 4.2% with insider buys disclosed

12:00am, Tuesday, 27'th Nov 2018

CorMedix Filing Shows Registration For $25M Common Stock Offering

12:00am, Thursday, 15'th Nov 2018

CorMedix misses by $0.05, beats on revenue

12:00am, Wednesday, 14'th Nov 2018

Conatus Pharmaceuticals among healthcare gainers; Clearside Biomedical leads the losers

12:00am, Monday, 05'th Nov 2018

48 Biggest Movers From Yesterday

12:00am, Wednesday, 17'th Oct 2018

40 Stocks Moving In Tuesday's Mid-Day Session

12:00am, Tuesday, 16'th Oct 2018

CorMedix shares are down 15.1% after the company filed for the sale of around 15 million shares of common stock, issuable upon the exercise of warrants held by selling shareholders.

Cormedix Stock News

CorMedix up 16% premarket on positive Neutrolin data

Mid-Day Market Update: Crude Oil Up 3%; Bio-Path Holdings Shares Plummet

Cormedix closes $7.5M senior secured convertible debt financing

Implied Volatility Surging for CorMedix (CRMD) Stock Options

Cormedix Receives Approval To Sell $5.4M Of NOL Tax Benefits Through The New Jersey Economic Development Authority Program

CorMedix up 7%

CorMedix Exec VP of Tech Operations Armstrong Buys 250,000 @ Avg Price: $1.45

CorMedix rebounds 4.2% with insider buys disclosed

CorMedix Filing Shows Registration For $25M Common Stock Offering

CorMedix misses by $0.05, beats on revenue

Conatus Pharmaceuticals among healthcare gainers; Clearside Biomedical leads the losers

48 Biggest Movers From Yesterday

40 Stocks Moving In Tuesday's Mid-Day Session

CorMedix shares are down 15.1% after the company filed for the sale of around 15 million shares of common stock, issuable upon the exercise of warrants held by selling shareholders.

Stocks Which Set New 52-Week High Yesterday, October 11th

Top Fintech Company